Rachel Sha, MBA

Rachel Sha is the CEO at Terrestrial Bio, a company focused on transforming the delivery of next generation therapies with its microarray skin patch that provides a patient friendly experience that is injection free and without the hassle of cold chain. Prior to Terrestrial, she was an Operating Partner at Engine Ventures, a venture fund spun-out of MIT that invests in Tough Tech companies primarily in the Boston area. She advised companies and worked with the investment team in exploring investment themes, opportunities, and programming. Before her time in venture, she spent seventeen years at Genzyme and Sanofi where she held leadership positions in business development, strategy, and commercial. Her last role at the firm was the Global Vice President of Digital Strategy, Partnering and Governance at Sanofi where she led global strategy, business development, and governance of digital programs to transform Sanofi and healthcare. She has long been a supporter of developing women entrepreneurs and has supported organizations like Mass Next Gen and Springboard Enterprises. She was recognized by the Boston Business Journal in the 2025 class of Women Who Lead in Life Sciences. Rachel holds a BS from Massachusetts Institute of Technology in Chemistry and an MBA from Harvard Business School.